Bristol Myers Squibb's Opdivo has been approved in a subcutaneous injection formulation by the FDA, making treatment easier for patients and potentially adding years to the product's patent life.
The FDA has started its review of a subcutaneous injection formulation of Eisai and Biogen's Alzheimer's drug Leqembi that could allow patients to receive maintenance doses at home, rather than in an ...
Self-administered injectable contraceptives, which are progestin-only shots taken at home every three months, have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback